Home Transcription factor FOXM1c is repressed by RB and activated by cyclin D1/Cdk4
Article
Licensed
Unlicensed Requires Authentication

Transcription factor FOXM1c is repressed by RB and activated by cyclin D1/Cdk4

  • Inken Wierstra and Jürgen Alves
Published/Copyright: July 20, 2006
Biological Chemistry
From the journal Volume 387 Issue 7

Abstract

The proliferation-stimulating transactivator FOXM1c (MPP2) is repressed by RB and activated by cyclin D1/Cdk4 and therefore behaves like E2F. Despite its strong transactivation domain, FOXM1c is kept almost inactive by two different inhibitory domains, the N-terminus and the central domain. The tumor suppressor RB binds directly to the central domain of FOXM1c and thereby indirectly represses the transactivation domain, so that the central domain of FOXM1c functions as an RB-recruiting negative-regulatory domain. Cyclin D1/Cdk4 releases FOXM1c from this repression by RB and from the repression by its own inhibitory N-terminus, thereby strongly activating FOXM1c. However, cyclin D1/Cdk4 does not directly affect the transactivation domain or the DNA-binding domain. By phosphorylation of RB, but not FOXM1c, cyclin D1/Cdk4 interrupts their direct interaction and thus abrogates the repression of FOXM1c by RB. Cyclin D1/Cdk4 also eliminates the inhibition of the transactivation domain by the N-terminus of FOXM1c, probably by interruption of their direct interaction. Consequently, the G1-phase proliferation signal cyclin D1/Cdk4 converts FOXM1c from an almost inactive form into a strong transactivator in G1-phase, i.e., just at the time point at which the transcriptional activity of FOXM1 is required for stimulation of the G1/S-transition.

:

Corresponding author

References

Adams, P.D. (2001). Regulation of the retinoblastoma tumor suppressor protein by cyclin/Cdks. Biochim. Biophys. Acta1471, M123–133.10.1016/S0304-419X(01)00019-1Search in Google Scholar

Adams, P.D. and Kaelin, W.G. (1995). Transcriptional control by E2F. Cancer Biol.6, 99–108.10.1006/scbi.1995.0013Search in Google Scholar

Blais, A. and Dynlacht, B.D. (2004). Hitting their targets: an emerging picture of E2F and cell cycle control. Curr. Opin. Genet. Dev.14, 527–532.10.1016/j.gde.2004.07.003Search in Google Scholar

Bousset, K., Oelgeschläger, M., Henriksson, M., Schreek, S., Burkhardt, H., Litchfield, D.W., Lüscher-Firzlaff, J.M., and Lüscher, B. (1994). Regulation of transcription factors c-Myc, Max and c-Myb by casein kinase II. Cell. Mol. Biol. Res.40, 501–511.Search in Google Scholar

Bracken, A.P., Ciro, M., Cocito, A., and Helin, K. (2004). E2F target genes: unraveling the biology. Trends Biochem. Sci.29, 409–417.10.1016/j.tibs.2004.06.006Search in Google Scholar

Cam, H. and Dynlacht, B.D. (2003). Emerging roles for E2F: beyond the G1/S transition and DNA replication. Cancer Cell3, 311–316.10.1016/S1535-6108(03)00080-1Search in Google Scholar

Chen, C.A. and Okayama, H. (1988). Calcium phosphate-mediated gene transfer: a highly efficient transfection system for stably transforming cells with plasmid DNA. Biotechnology6, 632–638.Search in Google Scholar

Ciemerych, M.A. and Sicinski, P. (2005). Cell cycle in mouse development. Oncogene24, 2877–2898.10.1038/sj.onc.1208608Search in Google Scholar

Classon, M. and Harlow, E. (2002). The retinoblastoma tumour suppressor in development and cancer. Nat. Rev. Cancer2, 910–917.10.1038/nrc950Search in Google Scholar

Cobrinik, D. (2005). Pocket proteins and cell cycle control. Oncogene24, 2796–2809.10.1038/sj.onc.1208619Search in Google Scholar

DeGregori, J. (2002). The genetics of the E2F family of transcription factors: shared functions and unique roles. Biochim. Biophys. Acta1602, 131–150.10.1016/S0304-419X(02)00051-3Search in Google Scholar

Dimova, D.K. and Dyson, N.J. (2005). The E2F transcriptional network: old acquaintances with new faces. Oncogene24, 2810–2826.10.1038/sj.onc.1208612Search in Google Scholar PubMed

Dyson, N. (1998). The regulation of E2F by pRB-family proteins. Genes Dev.12, 2245–2262.10.1101/gad.12.15.2245Search in Google Scholar

Evan, G.I. and Vousden, K.H. (2001). Proliferation, cell cycle and apoptosis in cancer. Nature411, 342–348.10.1038/35077213Search in Google Scholar

Ezhevsky, S.A., Nagahara, H., Vocero-Akbani, A.M., Gius, D.R., Wei, M.C., and Dowdy, S.F. (1997). Hypo-phosphorylation of the retinoblastoma protein (pRb) by cyclinD-Cdk4/6 complexes results in active pRb. Proc. Natl. Acad. Sci. USA94, 10699–10704.10.1073/pnas.94.20.10699Search in Google Scholar

Fernandez, P.C., Frank, S.R., Wang, L., Schroeder, M., Liu, S., Greene, J., Cocito, A., and Amati, B. (2003). Genomic targets of the human c-Myc protein. Genes Dev.17, 1115–1129.10.1101/gad.1067003Search in Google Scholar

Firzlaff, J.M., Lüscher, B., and Eisenman, R.N. (1991). Negative charge at the casein kinase II phosphorylation site is important for transformation but not for Rb binding by the E7 protein of human papillomavirus type 16. Proc. Natl. Acad. Sci. USA88, 5187–5191.10.1073/pnas.88.12.5187Search in Google Scholar

Flemington, E.K., Speck, S.H., and Kaelin, W.G. (1993). E2F-1 mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product. Proc. Natl. Acad. Sci. USA90, 6914–6918.10.1073/pnas.90.15.6914Search in Google Scholar

Frolov, M.V. and Dyson, N.J. (2004). Molecular mechanisms of E2F-dependent activation and RB-mediated repression. J. Cell Sci.117, 2173–2181.10.1242/jcs.01227Search in Google Scholar

Hahn, W.C. and Weinberg, R.A. (2002). Modelling the molecular circuitry of cancer. Nat. Rev. Cancer2, 331–341.10.1038/nrc795Search in Google Scholar

Hanahan, D. and Weinberg, R.A. (2000). The hallmarks of cancer. Cell100, 57–70.10.1016/S0092-8674(00)81683-9Search in Google Scholar

Harbour, J.W. and Dean, D.C. (2000). The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev.14, 2393–2409.10.1101/gad.813200Search in Google Scholar PubMed

Harbour, J.W., Luo, R.X., Dei Santi, A., Postigo, A.A., and Dean, D.C. (1999). Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1. Cell98, 859–869.10.1016/S0092-8674(00)81519-6Search in Google Scholar

Helin, K., Harlow, E., and Fattaey, A. (1993). Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol. Cell. Biol.13, 6501–6508.Search in Google Scholar

Hiebert, S.W. (1993). Regions of the retinoblastoma gene product required for its interaction with the E2F transcription factor are necessary for E2 promoter repression and pRb-mediated growth suppression. Mol. Cell. Biol.13, 3384–3391.Search in Google Scholar

Janknecht, R., Ernst, W.H., Pingoud, V., and Nordheim, A. (1993). Activation of ternary complex factor Elk-1 by MAP kinases. EMBO J.12, 5097–5104.10.1002/j.1460-2075.1993.tb06204.xSearch in Google Scholar

Kalinichenko, V.V., Gusariva, G.A., Tan, Y., Wang, I.C., Major, M.L., Wang, X., Yoder, H.M., and Costa, R.H. (2003). Ubiquitous expression of the Forkhead Box M1B transgene accelerates proliferation of distinct pulmonary cell types following lung injury. J. Biol. Chem.39, 37888–37894.10.1074/jbc.M305555200Search in Google Scholar

Kalinichenko, V.V., Major, M.L., Wang, X., Petrovic, V., Kuechle, J., Yoder, H.M., Dennewitz, M.B., Shin, B., Datta, A., Raychaudhuri, P., and Costa, R.H. (2004). Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor. Genes Dev.18, 830–850.10.1101/gad.1200704Search in Google Scholar

Korver, W., Roose, J., and Clevers, H. (1997a). The winged-helix transcription factor Trident is expressed in cycling cells. Nucleic Acids Res.25, 1715–1719.10.1093/nar/25.9.1715Search in Google Scholar

Korver, W., Roose, J., Heinen, K., Weghuis, D.O., de Bruijn, D., van Kessel, A.G., and Clevers, H. (1997b). The human TRIDENT/HFH-11/FKHL16 gene: structure, localization, and promoter characterization. Genomics46, 435–442.10.1006/geno.1997.5065Search in Google Scholar

Korver, W., Roose, J., Wilson, A., and Clevers, H. (1997c). The winged-helix transcription factor Trident is expressed in actively dividing lymphocytes. Immunobiol.198, 157–161.10.1016/S0171-2985(97)80036-8Search in Google Scholar

Krupczak-Hollis, K., Wang, X., Dennewitz, M.B., and Costa, R.H. (2003). Growth hormone stimulates proliferation of old-aged regenerating liver through Forkhead Box m1b. Hepatology38, 1552–1562.10.1016/j.hep.2003.08.052Search in Google Scholar PubMed

Krupczak-Hollis, K., Wang, X., Kalinichenko, V.V., Gusarova, G.A., Wang, I.C., Dennewitz, M.B., Yoder, H.M., Kiyokawa, H., Kaestner, K., and Costa, R.H. (2004). The mouse Forkhead Box m1 transcription factor is essential for hepatoblast mitosis and development of intrahepatic bile ducts and vessels during liver morphogenesis. Dev. Biol.276, 74–88.10.1016/j.ydbio.2004.08.022Search in Google Scholar PubMed

Lai, J.S. and Herr, W. (1992). Ethidium bromide provides a simple tool for identifying genuine DNA-independent protein associations. Proc. Natl. Acad. Sci. USA89, 6958–6962.10.1073/pnas.89.15.6958Search in Google Scholar PubMed PubMed Central

Laoukili, J., Kooistra, M.R.H., Brás, A., Kauw, J., Kerkhoven, R.M., Morrison, A., Clevers, H., and Medema, R.H. (2005). FoxM1 is required for execution of the mitotic programme and chromosome stability. Nat. Cell Biol.7, 126–136.10.1038/ncb1217Search in Google Scholar

Lundberg, A.S. and Weinberg, R.A. (1998). Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-CDK complexes. Mol. Cell. Biol.18, 753–761.10.1128/MCB.18.2.753Search in Google Scholar

Lüscher-Firzlaff, J.M., Westendorf, J.M., Zwicker, J., Burkhardt, H., Henriksson, M., Müller, R., Pirollet, F., and Lüscher, B. (1999). Interaction of the fork head domain transcription factor MPP2 with the human papilloma virus 16 E7 protein: enhancement of transformation and transactivation. Oncogene18, 5620–5630.10.1038/sj.onc.1202967Search in Google Scholar

Lüscher-Firzlaff, J.M., Lilischkis, R., and Lüscher, B. (2006). Regulation of transcription factor FOXM1c by Cyclin E/CDK2. FEBS Lett.580, 1716–1722.10.1016/j.febslet.2006.02.021Search in Google Scholar

Ma, R.Y., Tong, T.H., Cheung, A.M., Tsang, A.C., Leung, W.Y., and Yao, K.M. (2005). Raf/MEK/MAPK signaling stimulates the nuclear translocation and transactivating activity of FOXM1c. J. Cell Sci.118, 795–80610.1242/jcs.01657Search in Google Scholar

Major, M.L., Lepe, R., and Costa, R.H. (2004). Forkhead Box M1B transcriptional activity requires binding of Cdk-cyclin complexes for phosphorylation-dependent recruitment of p300/CBP coactivators. Mol. Cell. Biol.24, 2649–2661.10.1128/MCB.24.7.2649-2661.2004Search in Google Scholar

Malumbres, M. and Barbacid, M. (2001). To cycle or not to cycle: a critical decision in cancer. Nat. Rev. Cancer1, 222–231.10.1038/35106065Search in Google Scholar

Meyerson, M. and Harlow, E. (1994). Identification of G1 kinase activity for Cdk6, a novel cyclin D partner. Mol. Cell. Biol.14, 2077–2086.Search in Google Scholar

Obaya, A.J. and Sedivy, J.M. (2002). Regulation of cyclin-Cdk activity in mammalian cells. Cell. Mol. Life Sci.59, 126–142.10.1007/s00018-002-8410-1Search in Google Scholar

Oelgeschläger, M., Krieg, J., Lüscher-Firzlaff, J.M., and Lüscher, B. (1995). Casein kinase II phosphorylation site mutations in c-Myb affect DNA binding and transcriptional cooperativity with NF-M. Mol. Cell. Biol.15, 5966–5974.10.1128/MCB.15.11.5966Search in Google Scholar

Okabe, H., Satoh, S., Kato, T., Kitahara, O., Yanagawa, R., Yamaoka, Y., Tsunoda, T., Furukawa, Y., and Nakamura, Y. (2001). Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: Identification of genes involved in viral carcinogenesis and tumor progression. Cancer Res.61, 2129–2137.Search in Google Scholar

Oster, S.K., Ho, C.S.W., Soucle, E.L., and Penn, L.Z. (2002). The myc oncogene: MarvelouslYComplex. Adv. Cancer Res.84, 81–154.10.1016/S0065-230X(02)84004-0Search in Google Scholar

Pardee, A.B. (1989). G1 events and regulation of proliferation. Science246, 603–308.10.1126/science.2683075Search in Google Scholar

Pilarsky, C., Wenzig, M., Specht, T., Saeger, H.D., and Grutzmann, R. (2004). Identification and validation of commonly overexpressed genes in solid tumors by comparison of microarray data. Neoplasia6, 744–750.10.1593/neo.04277Search in Google Scholar

Qin, X.Q., Chittenden, T., Livingston, D.M., and Kaelin, W.G. (1992). Identification of a growth suppression domain within the retinoblastoma gene product. Genes Dev.6, 953–964.10.1101/gad.6.6.953Search in Google Scholar

Sellers, W.R., Novitch, B.G., Miyake, S., Heith, A., Otterson, G.A., Kaye, F.J., Lassar, A.B., and Kaelin, W.G. (1998). Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth. Genes Dev.12, 95–106.10.1101/gad.12.1.95Search in Google Scholar

Sherr, C.J. (2001). The INK4A/ARF network in tumour suppression. Nat. Rev. Mol. Cell Biol.2, 731–737.10.1038/35096061Search in Google Scholar

Sherr, C.J. and McCormick, F. (2002). The RB and p53 pathways in cancer. Cancer Cell2, 103–112.10.1016/S1535-6108(02)00102-2Search in Google Scholar

Sherr, C.J. and Roberts, J.M. (1999). CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev.13, 1501–1512.10.1101/gad.13.12.1501Search in Google Scholar

Sherr, C.J. and Roberts, J.M. (2004). Living with or without cyclins and cyclin-dependent kinases. Genes Dev.18, 2699–2711.10.1101/gad.1256504Search in Google Scholar

Stevens, C. and La Thangue, N.B. (2002). E2F and cell cycle control: a double-edged sword. Arch. Biochem. Biophys.412, 157–169.Search in Google Scholar

Teh, M.T., Wong, S.T., Neill, G.W., Ghali, L.R., Philpott, M.P., and Quinn, A.G. (2002). FOXM1 is a downstream target of Gli1 in basal cell carcinomas. Cancer Res.62, 4773–4780.Search in Google Scholar

Trimarchi, J.M. and Lees, J.A. (2002). Sibling rivalry in the E2F family. Nat. Rev. Mol. Cell Biol.3, 11–20.10.1038/nrm714Search in Google Scholar

van den Boom, J., Wolter, M., Kuick, R., Misek, D.E., Youkilis, A.S., Wechsler, D.S., Sommer, C., Reifenberger, G., and Hanash, S.M. (2003). Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time transcription-polymerase chain reaction. Am. J. Pathol.163, 1033–1043.10.1016/S0002-9440(10)63463-3Search in Google Scholar

Wang, I.C., Chen, Y.J., Hughes, D., Petrovic, V., Major, M.L., Park, H.J., Tan, Y., Ackerson, T., and Costa, R.H. (2005). Forkhead Box M1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase. Mol. Cell. Biol.25, 10875–10894.10.1128/MCB.25.24.10875-10894.2005Search in Google Scholar

Wang, X., Hung, N.J., and Costa, R.H. (2001a). Earlier expression of the transcription factor HFH-11B diminishes induction of p21CIP1/WAF1 levels and accelerates mouse hepatocyte entry into S-phase following carbon tetrachloride liver injury. Hepatology33, 1404–1414.10.1053/jhep.2001.24666Search in Google Scholar

Wang, X., Quail, E., Hung, N.J., Tan, Y., Ye, H., and Costa, R.H. (2001b). Increased levels of forkhead box M1B transcription factor in transgenic mouse hepatocytes prevent age-related proliferation defects in regenerating liver. Proc. Natl. Acad. Sci. USA98, 11468–11473.10.1073/pnas.201360898Search in Google Scholar

Wang, X., Krupczak-Hollis, K., Tan, Y., Dennewitz, M.B., Adami, G.R., and Costa, R.H. (2002a). Increased hepatic Forkhead Box M1B (FoxM1B) levels in old-aged mice stimulated liver regeneration through diminished p27Kip1 protein levels and increased Cdc25B expression. J. Biol. Chem.277, 44310–44316.10.1074/jbc.M207510200Search in Google Scholar

Wang, X., Kiyokawa, H., Dennewitz, M.B., and Costa, R.H. (2002b). The Forkhead Box m1b transcription factor is essential for hepatocyte DNA replication and mitosis during mouse liver regeneration. Proc. Natl. Acad. Sci. USA99, 16881–16886.10.1073/pnas.252570299Search in Google Scholar

Weinberg, R.A. (1995). The retinoblastoma protein and cell cycle control. Cell81, 323–330.10.1016/0092-8674(95)90385-2Search in Google Scholar

Wierstra, I. and Alves, J. (2006). Despite its strong transactivation domain transcription factor FOXM1c is kept almost inactive by two different inhibitory domains. Biol. Chem.387, 963–976.10.1515/BC.2006.120Search in Google Scholar PubMed

Wonsey, D.R. and Follettie, M.T. (2005). Loss of the forkhead transcription factor FoxM1 causes centrosome amplification and mitotic catastrophe. Cancer Res.65, 5181–5189.10.1158/0008-5472.CAN-04-4059Search in Google Scholar PubMed

Ye, H., Kelly, T.F., Samadani, U., Lim, L., Rubio, S., Overdier, D.G., Roebuck, K.A., and Costa, R.H. (1997). Hepatocyte nuclear factor 3/fork head homolog 11 is expressed in proliferating epithelial and mesenchymal cells of embryonic and adult tissues. Mol. Cell. Biol.17, 1626–1641.10.1128/MCB.17.3.1626Search in Google Scholar PubMed PubMed Central

Ye, H., Holterman, A.X., Yoo, K.W., Franks, R.R., and Costa, R.H. (1999). Premature expression of the winged helix transcription factor HFH-11B in regenerating mouse liver accelerates hepatocyte entry into S-phase. Mol. Cell. Biol.19, 8570–8580.10.1128/MCB.19.12.8570Search in Google Scholar PubMed PubMed Central

Zhang, H.S., Gavin, M., Dahiya, A., Postigo, A.A., Ma, D., Luo, R.X., Harbour, W.J., and Dean, D.C. (2000). Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF. Cell101, 79–89.10.1016/S0092-8674(00)80625-XSearch in Google Scholar

Published Online: 2006-07-20
Published in Print: 2006-07-01

©2006 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. 4th General Meeting of the International Proteolysis Society/International Conference on Protease Inhibitors
  2. Extracellular granzymes: current perspectives
  3. Impact of the N-terminal amino acid on targeted protein degradation
  4. Structural aspects of recently discovered viral deubiquitinating activities
  5. Cysteine cathepsins and caspases in silicosis
  6. The proprotein convertases and their implication in sterol and/or lipid metabolism
  7. PREPL: a putative novel oligopeptidase propelled into the limelight
  8. Human cathepsin L rescues the neurodegeneration and lethality in cathepsin B/L double-deficient mice
  9. Helicobacter pylori-induced downregulation of the secretory leukocyte protease inhibitor (SLPI) in gastric epithelial cell lines and its functional relevance for H. pylori-mediated diseases
  10. Increased local levels of granulocyte colony-stimulating factor are associated with the beneficial effect of pre-elafin (SKALP/trappin-2/WAP3) in experimental emphysema
  11. Interaction of a novel form of Pseudomonas aeruginosa alkaline protease (aeruginolysin) with interleukin-6 and interleukin-8
  12. Analysis of aldosterone-induced differential receptor-independent protein patterns using 2D-electrophoresis and mass spectrometry
  13. Modeling the 3D structure of wheat subtilisin/chymotrypsin inhibitor (WSCI). Probing the reactive site with two susceptible proteinases by time-course analysis and molecular dynamics simulations
  14. A stable analogue of glucose-dependent insulinotropic polypeptide, GIP(LysPAL16), enhances functional differentiation of mouse embryonic stem cells into cells expressing islet-specific genes and hormones
  15. Transcription factor FOXM1c is repressed by RB and activated by cyclin D1/Cdk4
  16. Despite its strong transactivation domain, transcription factor FOXM1c is kept almost inactive by two different inhibitory domains
  17. Inhibition of calcineurin by infusion of CsA causes hyperphosphorylation of tau and is accompanied by abnormal behavior in mice
  18. Isolation and properties of extracellular proteinases of Penicillium marneffei
  19. Isolation and comparative characterization of Ki-67 equivalent antibodies from the HuCAL® phage display library
Downloaded on 7.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/BC.2006.119/html
Scroll to top button